Multiresistant Escherichia coli meningitis after transrectal prostate biopsy;Méningite à Escherichia coli multirésistant après biopsie de prostate transrectale

Annales Francaises d'Anesthesie et de Reanimation

Volumn 26, Issue 1, 2007, Pages 88-90

  Samson, D ^a   Seguin, T ^a   Conil, J M ^a   Georges, B ^a   Samii, K ^a  

^a CHU RANGUEIL   (France)

Author keywords

Escherichia coli; Fluoroquinolones; Meningitis; Multiresistant; Prostate biopsy

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFADROXIL; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; FLUMEQUINE; GENTAMICIN; METRONIDAZOLE; NALIDIXIC ACID; NETILMICIN; NITROFURAN; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TICARCILLIN; TOBRAMYCIN SULFATE;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MENINGITIS; CASE REPORT; DEATH; DIAGNOSTIC PROCEDURE; HUMAN; MALE; PROPHYLAXIS; PROSTATE BIOPSY;

AGED; BIOPSY; DRUG RESISTANCE, MULTIPLE; FATAL OUTCOME; HUMANS; MALE; MENINGITIS, ESCHERICHIA COLI; PROSTATIC NEOPLASMS;

EID: 33846087686     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2006.08.011     Document Type: Article

References (18)

1. Aubert J. Complications des biopsies prostatiques Analyse d'une série de 4764 biopsies. Prog. Urol. 2 (1992) 484-487
2. Raaijmakers R., Blijenberg B.G., Finlay J.A., Rittenhouse H.G., Wildhagen M.F., Roobol M.J., et al. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 60 (2002) 826-830
3. Rodriguez L.V., and Terris M.K. Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. J. Urol. 160 (1998) 2115-2120
4. Société française d'anesthésie et de réanimation. Recommandations pour la pratique de l'antibioprophylaxie en chirurgie. Actualisation 1999. Ann. Fr. Anesth. Reanim. 18 (1999) fi75-fi85
5. Villers A., Mouton D., Rebillard X., Chautard D., Ruffion A., Staerman F., et al. Conditions de réalisation et schéma de ponctions lors d'une première série de biopsie prostatiques. Prog. Urol. 14 (2004) 144-153
6. Webb N.R., and Woo H.H. Antibiotic prophylaxis for prostate biopsy. BJU Inter 89 (2002) 824-828
7. Sandvik A., and Stefansen D. Escherichia coli meningitis following prostate biopsy. Tidsskr. Nor. Laegeforen. 102 (1982) 499-500
8. Meisel F., Jacobi C., Kollmar R., Hug A., Schwaninger M., and Schwab S. Acute meningitis after transrectal prostate biopsy. Urologe A. 42 (2003) 1611-1615
9. Shen Z.J., Chen S.W., Wang H., Zhou X.L., and Zhao J.P. Life-threatening meningitis resulting from transrectal prostate biopsy. Asian J. Androl. 7 (2005) 453-455
10. Rodriguez-Patron Rodriguez R., Navas Elorza E., Quereda Rodriguez-Navarro C., and Mayayo Dehesa T. Meningitis caused by multiresistant E. coli after an echo-directed transrectal biopsy. Actas Urol. Esp. 27 (2003) 305-307
11. Robert J., Cambau E., Grenet K., Trystram D., Pean Y., Fievet M.H., et al. Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992-1998. Clin. Microbiol. Infect. 7 (2001) 553-556
12. Trystram D., Grenet K., Cambau E., Pean Y., Fievet M.H., Jarlier V., et al. Evolution of susceptibility of aerobic Gram-negative aerobic bacilli to quinolones and fluoroquinolones in a university hospital (1992-2000). Pathol. Biol. (Paris) 50 (2002) 30-37
13. Talon D., Lallemand-De-Conto S., Thouverez M., and Bertrand X. E. coli: resistance to quinolones and betalactams of clinical strains isolated in the Franche-Comte region of France. Pathol. Biol. (Paris) 52 (2004) 76-81
14. Pena C., Albareda J.M., Pallares R., Pujol M., Tubau F., and Ariza J. Relationship between quinolones use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections. Antimicrob. Agents Chemother. 39 (1995) 520-524
15. Goettsch W., van Pelt W., Nagelkerke N., Hendrix M.G., Buiting A.G., Petit P.L., et al. Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands. J. Antimicrob. Chemother. 46 2 (2000) 223-228
16. Mahamat A., Lavigne J.P., Fabbro-Peray P., Kinowski J.M., Daures J.P., and Sotto A. Evolution of fluoroquinolone resistance among Escherichia coli urinary tract isolates from a French university hospital: application of the dynamic regression model. Clin. Microbiol. Infect. 11 (2005) 301-306
17. Maslow J.N., Lee B., and Lautenbach E. Fluoroquinolone-resistant Escherichia coli carriage in long-term care facility. Emerg. Infect. Dis. 11 (2005) 889-894
18. Otrock Z.K., Oghlakian G.O., Salamoun M.M., Haddad M., and Bizri A.R. Incidence of tract infection following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon. Infect. Control Hosp. Epidemiol. 25 (2004) 873-877